You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 8, August 27, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Crossroads: Conferences With Patients and Doctors
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICIAN'S CORNER
A 41-Year-Old Woman With Chronic Myelogenous Leukemia

Joseph H. Antin, MD, Discussant

JAMA. 2003;290:1083-1090.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

DR BURNS: Mrs P is a 41-year-old woman with chronic myelogenous leukemia (CML). She previously worked as a hairdresser but has not worked for several months. Mrs P lives with her husband and children. She has commercial insurance.

For a number of years, Mrs P noted that she felt fatigued and had headaches. She sought medical care, but no explanation was found. In June 2002, she went to a new primary care physician and was found to have a white blood cell count of 58 x 103/µL, hematocrit of 41.4%, and a platelet count of 211 x 103/µL. There were 51 polys, 2 monocytes, 1 eosinophil, 1 promyelocyte, 13 myelocytes, 14 bands, and 5 metamyelocytes. A bone marrow biopsy was performed and she was found to have a myeloproliferative disorder; cytogenetic testing showed classic Philadelphia chromosome (Ph).

Mrs P was seen . . . [Full Text of this Article]

MRS P, HER VIEW

AT THE CROSSROADS: QUESTIONS FOR DR ANTIN

Epidemiology of CML

Presenting Symptoms

Classification and Diagnosis

Natural History of CML

Prognosis

Laboratory Monitoring

Treatment Options

The Future

Recommendations for Mrs P

QUESTIONS AND DISCUSSION

Author Affiliation: Dr Antin is Chief, Stem Cell Transplantation Program, Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital. Professor of Medicine, Harvard Medical School.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.